By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Otonomy, Inc. 

6275 Nancy Ridge Drive
Suite 100
San Diego  California  92121  U.S.A.
Phone: 858-242-5200 Fax: 858-200-0933


Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics to address diseases of the inner and middle ear. There are no drugs currently approved by the FDA for the lead indications we are currently pursuing for our product candidates. Our lead candidate AuriPro completed Phase 3 clinical trials in pediatric patients with middle ear effusion at the time of tympanostomy tube placement surgery, and we have submitted a request to the FDA for approval. If approved, we anticipate a commercial launch in early 2016 and are building our business and commercial team to meet the needs of this next stage of our growth.

Key Statistics

Ownership: Public

Web Site: Otonomy
Symbol: OTIC


Company News
Otonomy (OTIC) Slashes 33% of Staff After Failed Phase III Clinical Trial for Meniere’s Disease 9/13/2017 6:58:03 AM
Otonomy (OTIC) Suspends Development of Lead Drug After Phase III Flop, Stock Plunges 8/30/2017 5:55:50 AM
Otonomy (OTIC) Reports Second Quarter 2017 Financial Results And Provides Corporate Update 8/4/2017 11:30:17 AM
Otonomy (OTIC) To Report Second Quarter 2017 Financial Results And Provide Corporate Update 7/27/2017 10:40:28 AM
Otonomy (OTIC) Announces FDA Acceptance Of OTIPRIO Supplemental New Drug Application Filing For Acute Otitis Externa 7/18/2017 10:50:00 AM
Otonomy (OTIC) Announces Successful End-Of-Phase II Review By FDA For OTIPRIO In Acute Otitis Media With Tympanostomy Tubes 6/22/2017 10:52:36 AM
Otonomy (OTIC) To Host Key Opinion Leader Meeting For Investors On Ménière's Disease 6/20/2017 10:05:50 AM
Otonomy (OTIC) Reports First Quarter 2017 Financial Results and Provides Corporate Update 5/5/2017 11:42:04 AM
Otonomy (OTIC) To Report First Quarter 2017 Financial Results And Provide Corporate Update 4/28/2017 10:06:53 AM
Otonomy (OTIC) Reports Fourth Quarter And Full Year 2016 Financial Results And Provides Corporate Update 3/3/2017 8:50:26 AM